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Abstract
Background: Genome-wide association studies found common variants in the fat mass and obesity-associated (FTO) 
gene associated with adiposity in Caucasians and Asians but the association was not confirmed in African populations. 
Association of FTO variants with insulin resistance and energy intake showed inconsistent results in previous studies. 
This study aimed to assess the influence of FTO variant rs9939609 on adiposity, insulin resistance, energy intake and 
physical activity in European - (EA) and African-American (AA) youth.
Methods: We conducted a cross-sectional study in EA and AA youths. One thousand, nine hundred and seventy-eight 
youths (48.2% EAs, 47.1% male, mean age 16.5 years) had measures of anthropometry. Percent body fat (%BF) was 
measured by dual-energy X-ray absorptiometry, visceral adipose tissue (VAT) and subcutaneous abdominal adipose 
tissue (SAAT) by magnetic resonance imaging. Energy intake and physical activity were based on self report from up to 
7 24-hour recalls. Physical activity was also measured by accelerometry.
Results: FTO rs9939609 was significantly associated with body mass index (BMI) (P = 0.01), weight (P = 0.03) and waist 
circumference (P = 0.04), with per-allele effects of 0.4 kg/m2, 1.3 kg and 0.8 cm, respectively. No significant association 
was found between rs9939609 and %BF, VAT, SAAT or insulin resistance (P > 0.05), or between rs9939609 and energy 
intake or vigorous physical activity (P > 0.05). No significant interactions of rs9939609 with ethnicity, gender, energy 
intake or physical activity were observed (P > 0.05).
Conclusions: The FTO variant rs9939609 is modestly associated with BMI and waist circumference, but not with energy 
intake or physical activity. Moreover, these effects were similar for EAs and AAs. Improved understanding of the effect of 
the FTO variant will offer new insights into the etiology of excess adiposity.
Background
Obesity is becoming an increasingly important clinical
and public health challenge worldwide and is associated
with several comorbidities such as type 2 diabetes, car-
diovascular diseases, metabolic syndrome and certain
forms of cancer [1-3]. Obesity results from the combined
effects of genes, environment and life style[4]. In this con-
text, an understanding of the effects of life style and genes
on obesity and also their interactions is important to pro-
vide a basis for determining the role they could have on
the development and prevention of obesity.
Lifestyle factors, including diet and physical inactivity,
are important contributors to weight gain and obesity.
However, previous studies showed inconsistent results
regarding the association of obesity with physical activ-
ity[5,6] or energy intake[7,8].
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Genetic factors play an important role in the develop-
ment of obesity. The identification of susceptibility genes
for obesity, especially common genetic variants in the
general population, therefore, is of great importance to
improve prediction and preventive efforts. Two indepen-
dent genome-wide association (GWA) studies firstly dis-
covered significant associations of common genetic
variants (rs9939609) in the fat mass and obesity-associ-
ated (FTO) gene [9,10] with body mass index (BMI) as a
measure of general obesity. Simultaneously a third study
identified the effect of FTO on obesity while testing for
population stratification [11]. The associations of FTO
and obesity-related phenotypes were further replicated in
various populations including Caucasians and Asians
[12-14], but could not be confirmed in an African popula-
tion[15]. The FTO gene was also reported to be associ-
ated with fasting glucose and insulin, but additional
adjustment for BMI abolished the association in some
studies[16,17], but not in others[18,19].
The function of FTO remains incompletely understood.
Because this gene is expressed particularly in the brain,
skeletal muscle and adipose tissue, FTO may be associ-
ated with fatness through effects on regulation of energy
homeostasis in the hypothalamus[20]. Two recent studies
suggested that the polyporphisms of the FTO gene were
associated with energy intake rather than energy expen-
diture[21,22]. However, other studies suggested there is
no association of FTO with either energy intake or energy
expenditure (e.g., physical activity)[23,24].
The main objectives of this study were, first, to assess
whether the previously identified common variant
rs9939609 in the FTO gene is associated with adiposity
and insulin resistance in African-American (AA) and
European-American (EA) youth available from the Geor-
gia Cardiovascular Twin study[25], the Lifestyle, Adipos-
ity and Cardiovascular Health in Youths (LACHY)
study[8] and the Adiposity Prevention through Exercise
(APEX) study[26]; second, to investigate the potential
interaction of rs9939609 with ethnicity, gender or lifestyle
behaviors(diet and physical activity); third, to investigate
whether rs9939609 has a direct influence on energy
intake and physical activity. In addition to anthropomet-
ric measures, more accurate indices for adiposity such as
visceral adipose tissue (VAT) and subcutaneous abdomi-
nal adipose tissue (SAAT) measured by magnetic reso-
nance imaging (MRI), and percentage of body fat (%BF)
based on dual-energy X-ray absorptiometry (DXA) were
used in our study.
Methods
Subjects
The present study included 1978 subjects from 3 cohorts,
the Georgia Cardiovascular Twin study [(n = 1210 twins
with 588 monozygotic (MZ) (291 pairs and 6 singletons)
and 622 dizygotic (DZ) twins (285 pairs and 52 single-
tons)], the LACHY study (n = 525, including 38 sib-pairs)
and the APEX study (n = 243, including 29 sib-pairs). All
twins in the Georgia Cardiovascular Twin study[25]were
recruited from public middle and high schools in the
Augusta, Georgia area and the cohort consisted of
roughly equal numbers of AAs and EAs (56.1% EA, 47.2%
male, mean age [standard deviation (SD)]: 18.1 [3.8]
years). All twin pairs were reared together and zygosity
was determined by genotyping 5 standard microsatellite
markers using buccal swabs or buffy coat DNA[27]. The
LACHY study consisted of approximately equal numbers
of EA and AA boys and girls (52.8% EA, 43.8% male) aged
14-18 years recruited from high schools in the Augusta,
Georgia area[8]. In the APEX study , subjects were AA
boys and girls only (53.6% male), aged 8 to 12 years
recruited from local elementary schools. Subjects eligible
for the study were only those that weighted <136.1 kg[26].
The criteria for classifying subjects as AAs or EAs using
self-identification of ethnicity have been described previ-
ously[28]. Subjects in all the 3 studies were apparently
healthy, free of any acute or chronic illness on the basis of
parental reports and were taking no medication that
could influence the results. The Institutional Review
Board at the Medical College of Georgia approved the
studies. Informed consent was obtained from all subjects
and by parents if subjects were <18 years of age.
Anthropometrics and body composition assessment
Height and weight were measured by standard methods
using a wall-mounted stadiometer and a digital scale,
respectively. BMI was calculated as weight/height2 (kg/
m2). Waist circumference (in cm) was measured twice at
the center of the umbilicus over the T-shirt and the values
were averaged. Skinfold thicknesses (i.e. triceps, subscap-
ular, and suprailiac) were measured on the right side of
the body with Lange calipers according to established
protocols[29]. Three sets of measurements for each skin-
fold were recorded and averaged. The inter-correlations
were >99%. Measurements of skinfold thickness were
available in 1976 subjects. BMI and the sum of the 3 skin-
fold thicknesses were used as measures of general adipos-
ity, while waist circumference was used as a measure of
central adiposity.
Biochemical assays
Fasting glucose and insulin concentrations were mea-
sured at the NIDDK supported Clinical Nutrition
Research Unit Core Laboratory at the University of Ala-
bama. Glucose was measured in 10 μL of sera using an
Ektachem DT II system (Johnson and Johnson Clinical
Diagnostic, Rochester, NY). Insulin was assayed in dupli-
cate 100-μL aliquots of serum by specific radioimmuno-
assay (Linco Research, Inc, St Charles, Mo). Cross-Liu et al. BMC Medical Genetics 2010, 11:57
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reactivity with proinsulin is <0.2%. Assay sensitivity was
3.41 mU/mL. The intra-assay coefficient of variation was
3.7%. Fasting glucose and insulin were only available in a
subsample of twins as twins coming on afternoon visits
were not required to fast.
Based on fasting glucose and insulin we used the
homeostasis model assessment (HOMA) 2 to calculate
insulin resistance (HOMA2-IR) and beta-cell function
(HOMA2-%B) using a nonlinear computer model as
specified in the HOMA2 software http://dtu.ox.ac.uk/
homa.
Dual-energy X-ray absorptiometry
In the LACHY study, %BF was measured using DXA
(Hologic QDR-4500W, software version 6.0, Waltham,
MA, USA). DXA provides reliable values for %BF[8].
Repeat measurements were performed using the QDR-
4500W machine with 219 adolescents and the intraclass
correlation coefficient (ICC) for %BF was found to be
0.99. For some subjects, DXA values were only available
from the Hologic QDR-1000W, but not from the Hologic
QDR-4500W model. For these individuals, %BF values
were derived from prediction equations based on 284
youths who were assessed on both instruments, using lin-
ear regression; ethnicity, gender and the QDR-1000W
measurement were the predictor variables. The multiple
R2 value for %BF was 0.99[30]. In the APEX study, all %BF
measurements were obtained using a Hologic QDR-1000
(Waltham, MA) as previously described, the ICC for %BF
was > 0.998 between two scans[31]. DXA calibration was
done each day, as specified by the Hologic Company.
DXA scans were not performed in the Georgia Cardio-
vascular Twin study.
Magnetic resonance imaging
In both the LACHY and APEX studies, VAT and SAAT
was determined using MRI (1.5 T General Electric Medi-
cal Systems, Milwaukee, WI) as described previously[32].
Briefly, with subjects in the supine position, a series of
five, 1-cm-thick, transverse images was acquired begin-
ning at the inferior border of the fifth lumbar vertebra
and proceeding toward the head. A gap is left between
the slices to avoid cross-talk. Values for VAT and SAAT
from a single image were calculated in terms of surface
area (cm2) and the volume (cm3) estimated by multiplying
the surface area by the image width (1 cm) and then sum-
ming the five images. VAT and SAAT were measured in
the Department of Radiology on equipment dedicated to
patient care. VAT and SAAT measures were obtained in
those subjects who underwent testing on days when the
MRI equipment was available for the research study.
Eventually, VAT and SAAT measurements were available
for 394 subjects. Measurements of VAT and SAAT were
not available in the Georgia Cardiovascular Twin study
and in the males of the APEX study.
Environmental variables
Free-living diet was measured with individual, non-con-
secutive, 24-h recalls that covered the period from mid-
night to midnight of the previous day. In the LACHY
study, we sought to obtain seven recalls from each partic-
ipant, one of each day of the week and only those subjects
that provided at least four recalls were included in the
analysis. The diet assessment has been previously
described in detail[8]. In the APEX study, two 24-h diet
recalls were obtained from each participant. Physical
activity was self-reported and quantified using our modi-
fied version of the previous day physical activity
recall[26], which recorded activities in 30-min time
blocks for 24-h period (midnight to midnight). Subjects
were asked to recall the activities concurrently with each
24-h diet recall and report at which level of effort (light,
moderate, hard, very hard) they engaged in each activity.
In the LACHY study, physical activity was measured with
MTI Actigraph monitors (model 7164; MTI Health Ser-
vices, Fort Walton Beach, FL)[33]. The daily mean num-
be r  o f  h o u r s  s pe n t  i n  vi g o r o u s  p h y s i c a l  a c t i v i t y  (V P A )
rather than those spent in moderate physical activity was
included in the present study, since only VPA was previ-
ously shown to be negatively associated with %BF[8]. No
measurements of free-living diet or physical activity were
available in the Georgia Cardiovascular Twin study.
Genotyping
DNA was extracted from buffy coats by using the
QiaAmp DNA Blood Mini Kit (Qiagen, Valencia, CA) or
from buccal swabs by using QuickExtract DNA Extrac-
tion Kit (Epicentre, Madison, WI). The FTO rs9939609
was genotyped by allelic discrimination Taqman assays
(Applied Biosystems, Foster City, CA). PCR were per-
formed in a 96-well format in a total of 5 μl reaction vol-
ume using 10 ng of genomic DNA and FAM/VIC dye
labeled allelic probes with the Taqman Universal Fast
Master mix and subjected to 95°C for 15 min, and 40
cycles of 95°C for 15 sec and 60°C for 1 min on an ABI
9800 Fast Thermocycler (Applied Biosystems, Foster
City, CA). The Taqman assay plates were transferred to
an ABI 7500 Fast Real Time PCR system in which the flu-
orescence intensity in each well of the plate was recorded
and genotypes were analyzed using Sequence Detection
Software 1.3. Genotyping quality control procedures
included genotyping 10% duplicates for accuracy check-
ing and inclusion of both positive and non-template con-
trols in each 96-well plate. Genotyping success rate was
99.5% for rs9939609. Genotyping accuracy as determined
by concordance between duplicates was 100%.Liu et al. BMC Medical Genetics 2010, 11:57
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Statistical Analyses
The main effects of the SNP on obesity-related pheno-
types were tested using structural equation modeling
with the statistical software Mx[34]. In this approach a
model is specified for both the means and the variance-
covariance matrices. We adapted the model described
previously[35] to include MZ twin pairs, DZ twin pairs(or
sib-pairs) and unpaired twins/singletons, which allows
for non-independent observations in twin and family
data. By modeling MZ and DZ (or sib-pair) covariances
separately we accounted for their different degrees of
relatedness. The SNP effect was analyzed in the com-
bined data from all 3 cohorts. Effects of age, ethnicity,
gender and cohort were regressed out for all variables
before using the residuals in Mx models. Gender and eth-
nicity-specific effects of the SNP were modeled as inter-
actions of the SNP with gender and/or ethnicity using
regression analyses within a generalized estimating equa-
tions (GEE) framework, which takes the non-indepen-
dency of twin and family data into account and yields
unbiased  P  values[36]. Furthermore, the associations
between rs9939609 and energy intake, physical activity, as
well as the interaction of rs9939609 with energy intake or
physical activity on adiposity-traits in the LACHY and
APEX studies including sib-pairs only were tested using
GEE.
I n  t h e  A P E X  s t u d y ,  s u b j e c t s  w e r e  r a n d o m i z e d  t o  a
physical activity intervention or control group. Obesity-
related phenotypes were measured three times, at the
baseline, mid- and end-point of the study. The measure-
ment at the baseline, prior to randomization, was used for
the analysis.
Hardy-Weinberg equilibrium (HWE) and ethnic differ-
ences in allele and genotype frequencies were tested by a
χ2 test in only one member per family (i.e, twins or sib
pairs), which was chosen randomly to prevent inflated
significance. All variables except %BF were log trans-
formed to obtain better approximations of the normal
distribution. Preliminary and GEE analyses were per-
formed using Stata 10 software (StataCorp, College Sta-
tion, TX). A P  value of ≤ 0.05 was considered to be
statistically significant.
Results
Participant characteristics
Descriptive statistics for age, height, adiposity and insulin
resistance related variables and environmental predictors
of adiposity in combined data of the 3 studies are pre-
sented by ethnicity and gender in Table 1. Effects of eth-
nicity, gender and their interaction were tested using GEE
with age and cohort identifier included as covariates. The
mean age of the total sample was 16.5 years. Many signif-
icant gender differences were observed, although some of
these were limited to one ethnic group. Similarly, many of
the significant ethnic differences were limited to either
males or females, as indicated in Table 1.
Environmental predictors of adiposity
Table 2 shows the regression analysis in LACHY and
APEX studies combined (n = 784) for BMI, waist circum-
ference, sum of skinfolds, %BF, VAT and SAAT. After
adjustment for age, ethnicity, gender, cohort and the
interaction between ethnicity and gender, VPA was nega-
tively related to sum of skinfolds (P = 0.01), %BF (P <
0.001) and SAAT (P = 0.05) accounting for 0.43%, 2.35%
and 1.11% of the variance respectively, but not to BMI (P
= 0.96), waist circumference (P = 0.83) or VAT (P = 0.45).
Energy intake was a negative determinant of BMI (P =
0.03), sum of skinfolds (P = 0.02), %BF (P < 0.001), VAT (P
= 0.02) and SAAT (P = 0.01) accounting for 0.61%, 0.74%,
1.82%, 1.16% and 1.21% of the variance respectively. Per-
centage of energy from carbohydrates (%CARBO) was
negatively associated with BMI (P = 0.02), sum of skin-
folds (P = 0.008) and %BF (P = 0.007) (Table 2). Percent-
age of energy from protein (%PRO) was a positive
predictor of BMI (P < 0.001), waist circumference (P <
0.001), sum of skinfolds (P < 0.001) and %BF (P < 0.001).
The relationship of dietary percentage of energy from fat
(%FAT) with these dependent variables was not signifi-
cant (Table 2).
Allele and genotype frequencies
Rs9939609 was common in both ethnic groups with
minor allele frequency (MAF) of 44.6% in EA and 48.4%
in AA. There was a significant difference in allele fre-
quencies between EA and AA subjects (P = 0.03), but no
significant difference in genotype frequencies (P = 0.08).
Rs9939609 was in HWE in both ethnic groups (P = 0.34
in EA and 0.92 in AA).
Associations between FTO rs9939609 and adiposity-
relatedphenotypes
We found modest association between rs9939609 and
BMI (per-allele effect of 0.4 kg/m2, P = 0.01), weight (per-
allele effect of 1.3 kg, P = 0.03), and waist circumference
(per-allele effect of 0.8 cm, P = 0.04) in additive models
(Figure 1). The explained percentages of variance were
0.24%, 0.20% and 0.16%, respectively. In a recessive
model, rs9939609 was also significantly associated with
BMI (P = 0.03), weight (P = 0.006), and waist circumfer-
ence (P = 0.02), with explained percentages of variance of
0.17%, 0.22% and 0.17%, respectively. The A allele carriers
showed higher sum of skinfold thicknesses, %BF, VAT
and SAAT compared to the TT allele carriers, but the dif-
ference did not reach statistical significance (Table 3). No
significant associations were found between rs9939609
and fasting glucose, fasting insulin, HOMA2-%B or
HOMA2-IR before or after additional adjustment forLiu et al. BMC Medical Genetics 2010, 11:57
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Table 1: General characteristics of study subjects
European-American (EA) African-American (AA) Ethnicity
P
(a/b)
Gender
P
(a/b)
male female male female
N mean (SD) N mean (SD) N mean (SD) N mean (SD)
Age, years 475 17.4(3.4) 478 17.8(3.4) 457 15.2(4.4) 568 15.8(4.5) 0.52 0.19
Anthropometry and adiposity
Height (cm) 475 173.4(9.0) 478 162.6(6.9) 457 165.2(16.0) 568 158.4(10.8) 0.67 < 0.001
Weight(kg) 475 69.9(18.2) 478 60.9(15.6) 457 63.8(22.3) 568 62.6(21.1) < 0.001** < 0.001
BMI(kg/m2) 475 23.1(5.1) 477 22.8(4.9) 457 22.8(5.4) 566 24.5(6.6) < 0.001** < 0.001##
Waist circumference (cm) 474 80.4(12.9) 476 75.2(12.8) 457 74.6(13.5) 568 75.9(14.9) 0.02* < 0.001#
Suprailiac skinfold (mm) 474 14.7(9.2) 478 18.7(9.7) 457 14.6(11.4) 568 20.7(12.0) 0.001** < 0.001
Subscapular skinfold 
(mm)
474 13.2(7.8) 478 16.7(8.5) 457 14.7(9.5) 567 20.3(11.1) < 0.001** < 0.001
Triceps skinfold (mm) 475 13.1(7.1) 477 20.5(7.4) 457 13.6(8.3) 568 21.6(9.7) 0.74 < 0.001
Sum of skinfolds (mm) 475 41.0(22.8) 477 55.9(24.0) 457 42.9(28.1) 567 62.7(31.3) 0.001** < 0.001
%BF 132 18.7(7.8) 144 29.4(7.1) 227 20.9(10.0) 265 29.5(8.5) 0.34 < 0.001
VAT(cm3) 64 95.8(56.2) 72 111.9(55.6) 70 67.0(49.6) 188 100.8(72.6) < 0.001* < 0.001
SAAT (cm3) 64 622.9(556.1) 72 903.4(517.2) 70 613.1(671.8) 187 1027.3(807.7) 0.05** < 0.001
Insulin resistance
Fasting glucose (mmol/L) 164 5.3(0.5) 175 5.0(0.5) 192 5.3(0.6) 284 5.0(0.5) 0.35/0.86 < 0.001/< 
0.001
Fasting insulin (pmol/L) 163 100.8(57.2) 169 94.2(58.0) 186 102.6(55.6) 282 131.9(76.4) < 0.001**/< 
0.001**
< 0.001##/
< 0.001##
HOMA2-%B 160 130.3(48.4) 169 137.4(50.0) 186 134.3(51.2) 281 174.3(64.2) < 0.001**/< 
0.001**
< 0.001##/
< 0.001##
HOMA2-IR 160 1.9(1.0) 169 1.7(1.0) 186 1.9(1.0) 281 2.4(1.3) < 0.001**/< 
0.001**
< 0.001##/
< 0.001##
Environmental variables
EI(Kilojoules/d) 134 9627.9
(2373.8)
146 7292.2
(2214.1)
233 8109.3
(2809.8)
268 6939.0
(2356.7)
0.006*/
0.005*
< 0.001/< 
0.001
%CARBO 134 53.4(6.3) 146 55.8(6.2) 233 51.0(7.2) 269 53.5(6.9) 0.001/0.004 < 0.001/< 
0.001
%PRO 134 14.4(2.8) 146 13.6(2.7) 233 14.4(3.0) 269 13.3(2.8) 0.39/0.15 < 0.001/< 
0.001
%FAT 134 32.8(4.8) 146 32.0(5.2) 234 35.2(5.8) 268 34.1(5.1) < 0.001/< 
0.001
0.009/
0.008
VPA (hours/d) 134 0.8(0.7) 146 0.4(0.5) 213 0.7(0.7) 257 0.3(0.5) 0.28/0.29 < 0.001/< 
0.001
BMI = body mass index; SD = standard deviation; %BF = percentage of body fat; VAT = visceral adipose tissue; SAAT = subcutaneous abdominal 
adipose tissue; HOMA2-%B = homeostasis model assessment 2 beta-cell function; HOMA2-IR = homeostasis model assessment 2 insulin 
resistance; EI = energy intake; %CARBO= percentage of energy from carbohydrates; %PRO= percentage of energy from protein; %FAT= 
percentage of energy from fat; VPA = vigorous physical activity.
N: number of subjects with phenotype and genotype data;
a: adjusted for age and cohort identifier; b: adjusted for age, cohort identifier and BMI
*significant only in males, **significant only in females, #significant only in EAs, ##significant only in AAs.Liu et al. BMC Medical Genetics 2010, 11:57
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BMI (Table 3). No significant interactions between
rs9939609 and ethnicity or gender were observed for any
of these adiposity-related phenotypes (P > 0.05). How-
ever, we further tested the associations between
rs9939609 and adiposity-related phenotypes in EAs and
AAs separately. We found that in both EAs and AAs, the
A allele carriers showed higher weight, BMI and waist
circumference compared to the TT allele carriers,
although the associations were significant (P = 0.02, 0.02
and 0.01, respectively) only in AAs (additional file 1:
Table S1).
Associations of FTO rs9939609 with energy intake and VPA 
in LACHY and APEX studies combined
No significant association was found between rs9939609
and the total energy intake, %CARBO, %PRO or %FAT.
Neither did we find association of rs9939609 with VPA
(irrespective of adjustment for BMI), whether assessed
through self-report in the combined LACHY and APEX
studies or accelerometry in the LACHY study (Table 4).
No significant gene-environment interactions between
rs9939609 and energy intake or VPA were observed for
any of the adiposity or insulin resistance-related pheno-
types (P > 0.05) (data not shown).
Discussion
In the current study, the association between a common
variant in the FTO gene and adiposity and insulin resis-
tance-related phenotypes was investigated in 1978 EA
and AA youths, available from the Georgia Cardiovascu-
lar Twin, LACHY and APEX studies. We replicated the
association between FTO  variant rs9939609 and BMI,
weight and waist circumference, which were modestly
significant. Effects of FTO rs9939609 did not depend on
ethnicity or gender. No significant associations of
rs9939609 with fasting glucose, fasting insulin or insulin
resistance were found, irrespective of correction for BMI;
Associations of rs9939609 with energy intake or vigorous
physical activity was not significant, nor were effects of
rs9939609 on adiposity modified by energy intake or vig-
orous physical activity.
In the LACHY and APEX studies, VPA was a negative
predictor of sum of skinfolds, %BF and SAAT, and energy
intake was a strong negative determinant of all dependent
variables except waist circumference. The inverse relation
between energy intake and adiposity could be explained
by the fact that individuals performing more free-living
physical activity tend to have less fat accumulation but at
the same time higher energy intake. The dietary %PRO
was a positive predictor for BMI, waist circumference,
sum of skinfolds and %BF, but the dietary %FAT was not
found to be a predictor of any obesity-related phenotype.
This finding is in line with a previous study on 6-14 year
old children, which showed that higher %PRO was associ-
ated with overweight after adjusting for age, gender and
total energy, whereas %FAT was not found to be a predic-
tor of BMI[37]. We found an inverse association between
%CARBO and BMI, sum of skinfolds and %BF, which is
consistent with a previous finding[38]. However, it
remains difficult to resolve cause and effect in cross-sec-
tional studies, in which energy intake and adiposity are
measured at the same time.
Table 2: Environmental predictors of BMI, waist circumference, sum of skinfolds, %BF, VAT and SAAT in the combined 
LACHY and APEX studies
BMI Waist 
circumference
Sum of skinfolds %BF VAT SAAT
β P %V β P %V β P %V β P %V β P %V β P %V
VPA (h/day) - 0.96 - + 0.83 -0 . 0 10.43 -  < 
0.001
2.35 - 0.45 - - 0.05 1.11
EI (Kilojoules/d) -0 . 0 3 0.61 - 0.84 -0 . 0 20.74 -  < 
0.001
1.82 -0 . 0 2 1.16 - 0.01 1.21
%CARBO - 0.02 0.48 - 0.09 - 0.008 0.78 - 0.007 0.73 - 0.96 - - 0.21 -
%PRO + <  
0.001
1.84 +  < 
0.001
1.19 +  < 
0.001
1.47 +  < 
0.001
1.29 + 0.81 - + 0.09 -
%FAT + 0.44 - + 0.66 + 0.20 - + 0.18 - - 0.84 - + 0.40 -
Based on the model with age, gender, ethnicity, cohort and the interaction of gender and ethnicity. Negative and positive indicate the direction 
of relation between the predictor and dependent variables. P < 0.05 are indicated in bold. %V = explained variance.
BMI = body mass index; %BF = percentage of body fat; VAT = visceral adipose tissue; SAAT = subcutaneous abdominal adipose tissue; VPA = 
vigorous physical activity; EI = energy intake; %FAT = percentage of energy from fat; %CARBO = percentage of energy from carbohydrates; 
%PRO= percentage of energy from protein.Liu et al. BMC Medical Genetics 2010, 11:57
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Since Frayling et al[10] first reported the significant
associations between the FTO variant rs9939609 and adi-
posity-related phenotypes such as BMI, weight, waist cir-
cumference, %BF and skinfolds in both children and
adults, several studies have replicated these findings in
Europeans[13,16] and Asians[12]. In our sample of EA
and AA youth, we replicated the significant associations
of rs9939609 with BMI, weight and waist circumference
using an additive model, although a recessive model was
more appropriate for weight and waist circumference.
Our per-A allele effect of 0.4 kg/m2 in BMI is similar to
the effect that Frayling reported in UK children at the age
of 11 years (0.4 kg/m2, P = 7 × 10-9) and a little higher
than that in Finnish children at the age of 14 years (0.1 kg/
m2,  P  = 0.04). We found that the variance in BMI
explained by rs9939609 was 0.24%, which is lower than
previously reported ~1.0%[10]. In addition, overall per-A
allele increases in weight (~1.3 kg) and waist circumfer-
ence (~0.8 cm) observed in our study were similar to the
effects reported by Frayling et al[10](~1.2 kg and ~1.0 cm,
respectively). Similar to Frayling et al[10], we found that
sum of skinfolds increased with the number of A allele
carried; however, the difference did not reach signifi-
cance. The lack of association between rs9939609 and
%BF is not in agreement with Frayling et al's finding in
children at 9 years of age[10]. The discrepancy in the
findings between the two studies could be partly due to
differences in population characteristics, such as age,
gender or ethnic composition, as well as environmental
exposures. Although the A-allele carriers had slightly
higher VAT and SAAT compared to TT carriers, we did
not find significant associations between rs9939609 and
VAT or SAAT. This might due to the smaller number of
subjects that had MRI examinations.
Table 3: Association between rs9939609 and adiposity-related phenotypes
Variables No. Mean (95%CI) χ2
(a/b)
P
(a/b)
Variance (%)
TT/AT/AA TT TA AA
Weight(kg) 599/962/417 61.5(60.4-62.6) 62.0(61.0-63.0) 64.1(62.6-65.7) 4.97 0.03 0.20
BMI(kg/m2) 599/962/414 22.5(22.2-22.9) 22.8(22.5-23.1) 23.3(22.8-23.8) 6.38 0.01 0.24
Waist 
circumference (cm)
599/960/416 75.1(74.3-76.0) 75.5(74.8-76.2) 76.7(75.6-77.9) 4.39 0.04 0.16
Suprailiac (mm) 599/962/417 14.4(13.7-15.0) 14.4(13.9-15.0) 14.7(13.7-15.6) 1.07 0.30 -
Subscapular(mm) 598/961/417 14.1(13.5-14.7) 14.1(13.6-14.6) 14.7(13.9-15.5) 2.28 0.13 -
Triceps(mm) 599/961/417 15.7(15.2-16.3) 15.6(15.1-16.1) 15.8(15.0-16.6) 0.37 0.55 -
Sum of 
skinfold(mm)
599/960/417 44.8(43.2-46.5) 44.9(43.4-46.4) 46.0(43.7-48.5) 1.24 0.27 -
%BF 183/377/208 24.9(23.7-26.1) 25.1(24.2-25.9) 25.2(24.0-26.4) 0.09 0.77 -
VAT(cm3) 97/187/110 78.0(69.5-87.5) 82.1(75.2-89.8) 78.3(68.9-89.0) 0.00 0.98 -
SAAT (cm3) 97/187/109 627.1(539.1-
729.6)
661.6(587.2-
745.4)
673.5(568.4-
798.0)
0.69 0.41 -
Fasting 
glucose(mmol/L)
213/391/211 5.07(5.02-5.13) 5.10(5.06-5.15) 5.10(5.05-5.16) 0.57/0.25 0.45/0.62 -
Fasting insulin 
(pmol/L)
208/387/205 94.4(88.6-
100.6)
99.7(94.8-
104.9)
94.8(86.5-
103.9)
0.66/0.19 0.42/0.67 -
HOMA2-%B 206/385/205 140.1(134.8-
145.7)
142.4(138.1-
146.8)
139.3(132.5-
146.4)
0.01/1.09 0.92/0.30 -
HOMA2-IR 206/385/205 1.7(1.6-1.9) 1.8(1.8-1.9) 1.8(1.6-1.9) 0.62/0.18 0.43/0.67 -
BMI = body mass index; %BF = percentage of body fat; VAT = visceral adipose tissue; SAAT = subcutaneous abdominal adipose tissue; HOMA2-
%B = homeostasis model assessment 2 β-cell function; HOMA2-IR = homeostasis model assessment 2 insulin resistance; P-values represent 
significance of the additive model (per-allele effect); Significant associations (P ≤ 0.05) are indicated in bold.
All variables are presented as means and 95%CI adjusted for age, gender, ethnicity and cohort identifier.
%variance = 100* (the difference of R-square value of the regression model additional with SNP compared to the base model).
a: adjusted for age, ethnicity, gender, cohort identifier;
b: adjusted for age, ethnicity, gender, cohort identifier and BMI.Liu et al. BMC Medical Genetics 2010, 11:57
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Previous studies reported associations of rs9939609
with fasting glucose, fasting insulin, or insulin resistance.
In most of these studies adjustment for BMI abolished
the associations[16,17], but in some studies they
remained significant[18,19]. We did not find any signifi-
cant associations before or after adjustment for BMI.
The FTO gene is significantly associated with weight,
BMI and other adiposity-related phenotypes. The mecha-
nism underlying the association of FTO gene and adipos-
ity may be due to a functional effect of FTO itself [39]. It
is known that FTO is highly expressed in the hypotha-
lamic region[40], an area that is known to be involved in
the regulation of appetite; and studies on the expression
of FTO suggest it might have a role in central control of
energy homeostasis[20,39]. Previous studies that have
investigated the association of rs9939609 with energy
intake and energy expenditure, physical activity, all
showed lack of association of rs9939609 with energy
expenditure or physical activity [21-23], but findings on
the associations with energy intake were inconsis-
tent[21,22,24,41,42]. We also investigated the role of
rs9939609 in the control of energy intake and physical
activity in the LACHY and APEX studies, in which mea-
sures on VPA and energy intake were available. No signif-
icant association was found between rs9939609 and self-
reported VPA. Similarly, no significant association was
Figure 1 Association between rs9939609 and weight, BMI and waist circumference. (1) Weight, BMI and waist circumference were presented 
as geometric mean and 95%CI adjusted for age, ethnicity, gender and cohort; (2) P values represent significance of the additive model, adjusted for 
age, gender, ethnicity and cohort identifier.
Table 4: Association of rs9939609 with energy intake, percentage of energy intake from carbohydrates, protein and fat 
and vigorous physical activity measured through recall and accelerometry
Variables No. Mean (SD) P
(a/b)
TT/AT/AA TT TA AA
EI(Kilojoules/d) 187/379/209 7958.8(2772.2) 7706.8(2698.3) 7883.9(2470.2) 0.75/0.79
%CARBO 187/379/210 53.3(7.3) 53.2(6.9) 53.2(6.7) 0.83/0.90
%PRO 187/380/209 13.9(2.9) 13.7(2.9) 14.2(2.8) 0.34/0.41
%FAT 186/380/210 33.6(5.3) 34.1(5.6) 33.5(5.2) 0.91/0.89
VPA (hours/d)c 181/359/204 0.5(0.6) 0.5(0.6) 0.6(0.6) 0.63/0.62
VPA (mins/d)d 123/221/129 4.8(7.5) 5.3(7.2) 3.9(7.2) 0.26
P-values represent significance of the additive model (per-allele effect);
EI = energy intake; %CARBO = percentage of energy from carbohydrates; %PRO = percentage of energy from protein; %FAT= percentage of 
energy from fat; VPA = vigorous physical activity.
a: adjusted for age, ethnicity, gender;
b: adjusted for age, ethnicity, gender and BMI;
c: recalled VPA in the LACHY and APEX study;
d: measured VPA through accelerometer in the LACHY study.Liu et al. BMC Medical Genetics 2010, 11:57
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found between rs9909609 and VPA measured through
accelerometry. Furthermore, we estimated energy expen-
diture through physical activity, weight and metabolic
equivalents assigned to different activity categories. No
significant association was found between rs9939609 and
energy expenditure (data not shown), which is in line
with previous studies that did assess energy expenditure
directly through more sophisticated means[23,41]. We
did not find significant association between rs9939609
and energy intake, which is in line with the findings of
Hakanen et al [24] and Sonestedt et al [42], but inconsis-
tent with the findings of other studies [21,22,41,43]. A
study in 2726 Scottish children found that rs9939609
does not appear to be involved in the regulation of energy
expenditure, but may have a role in the control of food
intake and food choice[41]. In 3337 UK children, Wardle
et al found that the rs9939609 A allele is likely to exert its
effects by influencing appetite[44] and the T allele might
be protective against overeating by promoting respon-
siveness to internal signals of satiety[43]. Currently little
is known about the function of the FTO gene. Functional
tests in mice indicated that FTO may play a role in adipo-
cyte function but not adipogenesis[45]. Wåhlén et al
[46]studied FTO with regard to fat cell function and adi-
pose tissue gene expression, their results suggested that
FTO  might be involved in body weight regulation
through lipolysis. In our study, we did not observe signifi-
cant association between rs9939609 and energy intake.
However, based on our current sample size, the power to
detect 1% of the total variance for energy intake is only
about 70%. Thus, the non-significant associations should
be interpreted with caution, and will provide useful infor-
mation for future meta-analysis efforts.
Previous studies reported that low physical activity
accentuated the effect of rs9939609 on body fat accumu-
lation[47]. However, we did not find any interaction of
rs9939609 with physical activity on any phenotype
related to adiposity, which is in line with a number of
other studies[48,49]. In our study, contrary to Sonestedt
et al's finding [42], we did not observe a significant inter-
action of rs9939609 with fat or carbohydrate intake on
BMI, which might be due to our smaller sample size.
Studying populations of different ancestry will help to
globally identify and understand the genetic and environ-
m e n t a l  f a c t o r s  a s s o c i a t e d  w i t h  o b e s i t y .  A s  s u c h ,  w e
included AAs as well as EAs in our study. The MAF in
EAs (0.45) in our study was the same as that reported in
HapMap, while the MAF in AAs (0.48) was slightly lower
(0.52 in HapMap). The MAF in EAs was a little higher
than reported in another study[10]. The association
between rs9939609 and BMI has been firmly established
in Europeans[9-11,14], but the findings in populations of
African ancestry are inconsistent [15,50]. In 604 middle-
aged AAs, rs9939609 was significantly associated with
BMI and waist circumference (P  = 0.014 and 0.034,
respectively)[50], which is in line with our findings. How-
ever, this association could not be confirmed in a native
African population[15], This might represent a true lack
of association, but it is also possible that any effect of
FTO genotype on adiposity is of limited relevance in a
lean population where little excess food is available com-
pared to a similar ethnic population in an obesogenic
environment. In a large sample of African Americans, no
significant association was found between adiposity and
FTO  variant rs8050136, which is in high LD with
rs9939609 (r2 = 0.82 in YRI population)[13]. We found
significant association between rs9939609 and BMI,
weight and waist circumference in the combined EA and
AA samples. Although the MAF in EAs was significantly
different from those in AAs, no interaction between
rs9939609 and ethnicity was observed for weight, BMI or
other adiposity-related phenotypes. Thus, our findings
suggest that the effects of rs9939609 on obesity-related
phenotypes were similar for EAs and AAs. For example,
the per-allele effect on BMI was 0.35 kg/m2 and 0.45 kg/
m2 in EAs and AAs, respectively. This finding provides
useful information in understanding the role of FTO vari-
ants in adiposity of multi-ethnic populations.
The major strengths of our study are (1) the inclusion of
in-depth estimates based on multiple self reports of both
dietary energy intake and physical activity, which allowed
us to investigate the direct association with rs9939609
and their potential interactions with the SNP in their
effect on adiposity; and (2) the use of %BF by DXA and
VAT and SAAT by MRI, which are more precise mea-
sures of general and/or central adiposity than BMI and
waist circumference. Furthermore, the inclusion of AA as
well as EA youth allowed us to investigate a potential
interaction of rs9939609 with ethnicity. Several limita-
tions of our study need to be acknowledged as well. In the
Georgia Cardiovascular Twin study, no measurements of
%BF, VAT and SAAT were available since DXA scans and
MRI examinations were not performed. Meanwhile, in
the twin study, fasting glucose and insulin were only
available from part of the subjects since fasting was not
requested for twins examined in the afternoon. Sexual
maturation was not assessed in the twin cohort and could
not be incorporated as a covariate. A final limitation is
that our recall measures of free-living diet and physical
a c t i v i t y  w e r e  b a s e d  o n  s e l f  r e p o r t  a n d  n o t  m e a s u r e d
directly.
Conclusion
In summary, we replicated in a large sample of EA and
AA youth the significant association between the FTO
variant rs9939609 and BMI, weight and waist circumfer-
ence, and these effects are similar for EAs and AAs.
Moreover, we did not find any significant associationLiu et al. BMC Medical Genetics 2010, 11:57
http://www.biomedcentral.com/1471-2350/11/57
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between rs9939609 and energy intake or physical activity.
Furthermore, we did not observe any significant interac-
tions between rs9939609 and gender, energy intake or
physical activity for any adiposity-related phenotypes.
These findings may be helpful in improving our under-
standing of the underlying mechanism and pathways
whereby the variant influences the development of adi-
posity.
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